Document is current

Any future updates will be listed below

Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis

Crossref DOI link: https://doi.org/10.1038/s41401-024-01427-0

Published Online: 2024-12-03

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark